We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+6.3%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.37B
AUM Growth
-$13.6M
Cap. Flow
+$14.5M
Cap. Flow %
0.61%
Top 10 Hldgs %
39.42%
Holding
115
New
26
Increased
36
Reduced
14
Closed
20

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$60.1M
2
AMZN icon
Amazon
AMZN
+$54.1M
3
YUM icon
Yum! Brands
YUM
+$51M
4
RPRX icon
Royalty Pharma
RPRX
+$39.8M
5
ETNB
89bio
ETNB
+$28.8M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$102M
2
TPR icon
Tapestry
TPR
+$83M
3
LVS icon
Las Vegas Sands
LVS
+$78.1M
4
UNP icon
Union Pacific
UNP
+$56.7M
5
T icon
AT&T
T
+$54.3M

Sector Composition

Rank Sector Weight
1 Healthcare 47.29%
2 Consumer Discretionary 12.85%
3 Technology 6.69%
4 Communication Services 5.61%
5 Consumer Staples 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGX icon
76
argenx
ARGX
$54.1B
$1.26M 0.05%
3,390
+1,870
+123% +$692K
SNY icon
77
Sanofi
SNY
$104B
$1.23M 0.05%
22,610
– –
SYRE icon
78
Spyre Therapeutics
SYRE
$9.25B
$1.18M 0.05%
162,396
– –
CI icon
79
Cigna
CI
$74.6B
$1.02M 0.04%
+4,000
New +$1.17M
VKTX icon
80
Viking Therapeutics
VKTX
$4B
$999K 0.04%
+60,000
New +$620K
WAT icon
81
Waters Corp
WAT
$39.9B
$975K 0.04%
3,150
+2,200
+232% +$712K
BSX icon
82
Boston Scientific
BSX
$71.5B
$913K 0.04%
18,241
+4,100
+29% +$193K
SYK icon
83
Stryker
SYK
$130B
$845K 0.04%
2,960
+1,300
+78% +$345K
PODD icon
84
Insulet
PODD
$9.79B
$791K 0.03%
+2,480
New +$735K
A icon
85
Agilent Technologies
A
$41.2B
$690K 0.03%
+4,990
New +$730K
DXCM icon
86
DexCom
DXCM
$32B
$683K 0.03%
+5,880
New +$658K
MCK icon
87
McKesson
MCK
$101B
$652K 0.03%
1,830
-56,278
-97% -$20.3M
IDXX icon
88
Idexx Laboratories
IDXX
$46.2B
$460K 0.02%
920
– –
ISRG icon
89
Intuitive Surgical
ISRG
$134B
$396K 0.02%
1,550
– –
AVTR icon
90
Avantor
AVTR
$9.19B
$326K 0.01%
+15,400
New +$351K
UTHR icon
91
United Therapeutics
UTHR
$23.1B
$305K 0.01%
+1,360
New +$335K
MTD icon
92
Mettler-Toledo International
MTD
$28.6B
$251K 0.01%
164
– –
CRL icon
93
Charles River Laboratories
CRL
$12.8B
$204K 0.01%
1,010
– –
BNTC icon
94
Benitec Biopharma
BNTC
$468M
$161K 0.01%
45,235
– –
OHAAW
95
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$10.9K ﹤0.01%
72,605
– –
ATAI icon
96
AtaiBeckley Inc
ATAI
$2.68B
– –
-1,637,960
Closed -$4.36M
BIIB icon
97
Biogen
BIIB
$30.7B
– –
-1,430
Closed -$396K
BMRN icon
98
BioMarin Pharmaceuticals
BMRN
$12.4B
– –
-2,670
Closed -$276K
BMY icon
99
Bristol-Myers Squibb
BMY
$132B
– –
-3,280
Closed -$236K
DFS
100
DELISTED
Discover Financial Services
DFS
– –
-166,809
Closed -$16.3M
1 2 3
4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, Suvretta Capital Management held 115 positions worth $2.37B, down 0.57% from $2.38B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Suvretta Capital Management's Q1 2023 filing shows 26 new, 36 increased, 14 reduced and 20 closed positions. Its largest new stake was Amazon: 559,490 shares worth $57.8M. The largest sale was Otis Worldwide, an estimated $102M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Suvretta Capital Management's largest Q1 2023 buy was Amazon: 559,490 shares worth $57.8M.
  • Suvretta Capital Management added most to Elevance Health in Q1 2023, an estimated $60.1M increase.
  • Suvretta Capital Management's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $56.7M.
  • Suvretta Capital Management fully exited Otis Worldwide in Q1 2023, selling an estimated $102M.
  • Suvretta Capital Management's ten largest holdings make up 39% of its $2.37B portfolio in Q1 2023.
  • Suvretta Capital Management opened 26 new positions and closed 20 in Q1 2023.
  • Suvretta Capital Management's portfolio value fell 0.57% quarter-over-quarter to $2.37B.

Based on Suvretta Capital Management's 13F filing for Q1 2023, filed 15 May 2023.